Protagonist Therapeutics is a biotechnology company dedicated to the discovery of novel peptide and small molecule compounds that mimic or inhibit therapeutically-relevant protein-protein interactions.
Type
Public
HQ
Milpitas, US
Founded
2007
Size (employees)
49 (est)+69%
Protagonist Therapeutics was founded in 2007 and is headquartered in Milpitas, US
Report incorrect company information

Key People/Management at Protagonist Therapeutics

Dinesh Patel

Dinesh Patel

President & CEO
David Y. Liu

David Y. Liu

Chief Scientific Officer
Mark Smythe

Mark Smythe

Vice President of Technology & Alliances

Protagonist Therapeutics Office Locations

Protagonist Therapeutics has an office in Milpitas
Milpitas, US (HQ)
100 521 Cottonwood Dr
Show all (1)
Report incorrect company information

Protagonist Therapeutics Financials and Metrics

Protagonist Therapeutics Financials

USD

Net income (Q1, 2018)

(7.7 m)

EBIT (Q1, 2018)

(8.2 m)

Market capitalization (22-Jun-2018)

145.2 m

Closing share price (22-Jun-2018)

6.9

Cash (31-Dec-2017)

106 m
Protagonist Therapeutics's current market capitalization is $145.2 m.
Annual
USDFY, 2016FY, 2017

General and administrative expense

7 m11.8 m

R&D expense

25.7 m46.2 m

Operating expense total

32.7 m58 m

EBIT

(32.7 m)(37.9 m)
Quarterly
USDQ2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

General and administrative expense

1.4 m1.6 m3 m3.1 m3.6 m

R&D expense

5.7 m5.6 m11.3 m12 m15.4 m

Operating expense total

7.1 m7.1 m14.3 m15.1 m19 m

EBIT

(7.1 m)(7.1 m)(14.3 m)(15.1 m)(8.2 m)
Annual
USDFY, 2016FY, 2017

Cash

21.1 m106 m

Inventories

3.4 m

Current Assets

83.2 m150.9 m

PP&E

562 k879 k
Quarterly
USDQ2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

13.8 m96 m9.5 m10.4 m

Current Assets

22.4 m102.2 m67.5 m69.1 m

PP&E

599 k564 k641 k903 k

Total Assets

24.5 m102.8 m82.7 m70.5 m
Annual
USDFY, 2016FY, 2017

Net Income

(37.2 m)(37 m)

Depreciation and Amortization

317 k406 k

Inventories

(1.8 m)

Accounts Payable

(115 k)91 k
Quarterly
USDQ2, 2016Q3, 2016Q1, 2017Q1, 2018

Net Income

(7.1 m)(7.1 m)(14.1 m)(7.7 m)

Depreciation and Amortization

78 k

Accounts Payable

1.4 m2.3 m1.1 m21 k

Cash From Operating Activities

(15.1 m)
Show all financial metrics
Report incorrect company information

Protagonist Therapeutics News and Updates

Report incorrect company information